Myocardial Scar Detected by Contrast-Enhanced Cardiac Magnetic Resonance Imaging is Associated with Ventricular Tachycardia in Hypertrophic Cardiomyopathy Patients

Heart Lung and Circulation

Volumn 17, Issue 5, 2008, Pages 370-374

  Suk, Tiffany ^a   Edwards, Colin ^a   Hart, Hamish ^a   Christiansen, Jonathan P ^a  

^a NORTH SHORE HOSPITAL   (New Zealand)

Author keywords

Cardiac magnetic resonance imaging; Hypertrophic cardiomyopathy; Ventricular tachycardia

Indexed keywords

GADODIAMIDE; GADOLINIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART VENTRICLE TACHYCARDIA; HEART VENTRICLE WALL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MYOCARDIAL SCAR; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCAR; SENSITIVITY AND SPECIFICITY;

CARDIOMYOPATHY, HYPERTROPHIC; CICATRIX; COHORT STUDIES; CONTRAST MEDIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 50549100858     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hlc.2008.03.080     Document Type: Article

References (17)

1. Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Bardy G.H., Favale S., Rea R.F., Boriani G., Estes M., Spirito P., Casey S.A., Stanton M.S., and Betocchi S. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 342 (2000) 365-373
2. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., and Torbicki A. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42 9 (2003) 1687-1713
3. Varnava A.M., Elliott P.M., Mahon N., Davies M.J., and McKenna W.J. Relationship between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 31 (2001) 988-998
4. Kim R.J., Shah D.P., and Judd R.M. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 5 3 (2003) 505-514
5. Choudhury L., Mahrholdt H., Wagner A., Choi K.M., Elliott M.D., Klocke F.J., Bonow R.O., Judd R.M., and Kim R.J. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 12 (2002) 2156-2164
6. Moon J.C.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 9 (2003) 1561-1567
7. Papavassiliu T., Schnabel P., Schroder M., and Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J 26 22 (2005) 2395
8. Moon J.C.C., Reed E., Sheppard M.N., Elkington A.G., Ho S.Y., Burke M., Petrou M., and Pennell D.J. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264
9. Klues H.G., Schiffers A., and Maron B.J. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol 26 (1995) 1699-1708
10. Maron B.J., and McKenna W.J. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 42 (2003) 1687-1713
11. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., Pennell D.J., Rumberger J.A., Ryan T., and Verani M.S. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 4 (2002) 539-542
12. Kuirbayashi T., and Roberts W.C. Myocardial disarray at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy. Am J Cardiol 70 (1992) 1333-1340
13. Elliott P.M., Gimeno Blanes J.R., Mahon N.G., Poloniecki J.D., and McKenna W.J. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357 (2001) 420-424
14. Basso C., Thiene G., Corrado D., Buja G., Melacini P., and Nava A. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischaemia. Hum Pathol 31 (2000) 988-998
15. Nazarian S., Bluemke D.A., Lardo A.C., Zviman M.M., Watkins S.P., Dickfeld T.L., Meininger G.R., Roguin A., Calkins H., Tomaselli G.F., Weiss R.G., Berger R.D., Lima J.A.C., and Halperin H.R. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in non-ischaemic cardiomyopathy. Circulation 112 (2005) 2821-2825
16. Assomull R.G., Prasad S.K., Lyne J., Smith G., Burman E.D., Khan M., Sheppard M.N., Poole-Wilson P.A., and Pennell D.J. Cardiovascular magnetic resonance, fibrosis and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48 (2006) 1977-1985
17. Kwong R.Y., Chan A.K., Brown K.A., Chan C.W., Reynolds H.G., Tsang S., and Davis R.B. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113 (2006) 2733-2743